Independent report

Use of the AstraZeneca COVID-19 vaccine: JCVI statement

Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.

• From: Department of Health and Social Care
• Published: 7 April 2021

Documents

JCVI statement on use of the AstraZeneca COVID-19 vaccine: 7 April 2021

HTML

Details

Statement from the Joint Committee on Vaccination and Immunisation (JCVI) following reports of an extremely rare adverse event after vaccination with the first dose of the AstraZeneca COVID-19 vaccine.

Published 7 April 2021